"Advancements in Pancreatic Cancer Detection: The Promise of Liquid Biopsy and Blood Tests"
A new blood test has shown promise in detecting early-stage pancreatic cancer with up to 97% accuracy by identifying genetic markers shed by the cancer. When combined with an existing pancreatic cancer marker test, the accuracy increased to 97% for stage 1 and 2 cancers. The test offers potential for early detection, which is crucial as pancreatic cancer is often diagnosed at advanced stages. However, further research is needed before it can be widely used.
